Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Cardiovascular safety of obesity treatment naltrexone-bupropion uncertain

Science Daily - 8 Mar 2016 22:31
The cardiovascular safety of the obesity treatment naltrexone-bupropion remains uncertain because of the unanticipated early termination of a trial to determine its safety, according to a study.
Full Article at Science Daily

More Science News
1
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard